StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a report released on Monday morning. The firm issued a buy rating on the stock.

Mannatech Trading Up 1.3 %

MTEX opened at $7.60 on Monday. The firm has a market capitalization of $14.33 million, a PE ratio of -8.54 and a beta of 1.17. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.17 and a quick ratio of 0.62. Mannatech has a fifty-two week low of $6.75 and a fifty-two week high of $11.80. The company’s 50-day moving average is $7.39 and its 200 day moving average is $7.71.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) EPS for the quarter. The company had revenue of $27.74 million during the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%.

Insiders Place Their Bets

In other news, Director Larry A. Jobe sold 16,288 shares of the stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the sale, the director now owns 54,721 shares in the company, valued at $424,087.75. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 41.50% of the company’s stock.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.